Soros Fund Management BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 234 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 1.6%.

Soros Fund Management ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$343,539
+87.9%
2,272,535
+81.1%
5.87%
+80.2%
Q2 2022$182,8661,255,0013.26%